Price
Target price
€0.66
€0.66
-4.930%
-0.034
-4.930%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tempramed Technologies Ltd. Stock
Tempramed Technologies Ltd. took a tumble today and lost -€0.034 (-4.930%).
Pros and Cons of Tempramed Technologies Ltd. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
News
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network
Initial shipment delivered to distributor warehouse supports expansion into B2B pharmacy distribution alongside direct-to-consumer activities
Vancouver, BC - January 7, 2026 - TempraMed
TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026
Vancouver, BC – January 2, 2026 – TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (“TempraMed” or the “Company”), a medical technology innovator transforming how temperature-sensitive
TempraMed Launches New Product, VIVI Cap Smart, Expanding its Portfolio to Include a Digital Health Offering
Integrated smart technology builds on TempraMed’s proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medication
Highlig